2192 — Medlive Technology Co Share Price
0.000.00%
Last trade - 00:00- HK$8.53bn
- HK$4.16bn
- CNY558.46m
- 79
- 28
- 90
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 23.82 | ||
| PEG Ratio (f) | 4.39 | ||
| EPS Growth (f) | 5.74% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.67 | ||
| Price to Tang. Book | 1.77 | ||
| Price to Free Cashflow | 91.73 | ||
| Price to Sales | 14.36 | ||
| EV to EBITDA | 26.82 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.96% | ||
| Return on Equity | 6.71% | ||
| Operating Margin | 61.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 213.53 | 284.44 | 314.05 | 412 | 558.46 | 723.18 | 919.95 | 35.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +170.34 | -24.34 | +70.96 | +108.2 | +29.87 | +4.79 | +8.69 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medlive Technology Co Ltd is an investment holding company primarily engaged in the provision of precision marketing and corporate solutions, medical knowledge solutions, and intelligent patient management solutions. The precision marketing solutions provide digital detailing, digital marketing consulting and digital content creation services. The corporate solutions provide digital market research, electronic data capture (EDC), and clinical data management system (CDMS) solutions, real-world studies (RWS) support solutions and other services. The medical knowledge solutions provide professional medical information covering continuing medical education and clinical decision support. The intelligent patient management solutions provide patient education services to patients and non-profit organizations, including content development, application software development and other related services. The Company conducts its business in the domestic and overseas markets.
Directors
- Liping Tian CHM (54)
- Lijun Tian VPR (47)
- Xin Zhou VPR (40)
- Jiangtao Xin VPR (44)
- Liancheng Yang VPR (42)
- Lixin Tian EDR (52)
- Juan Liu OTH (37)
- Jiang Nan OTH (33)
- Kar Yee Szeto SEC
- Yanling Yang SEC
- Zhuolin Li NED (38)
- Eiji Tsuchiya NED (56)
- Jun Ma NID (66)
- Shan Wang NID (47)
- Richard Yeh NID (52)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 8th, 2013
- Public Since
- July 15th, 2021
- No. of Employees
- 747
- Sector
- Media & Publishing
- Industry
- Consumer Cyclicals
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 732,876,000
- Address
- Ugland House, BEIJING, KY1-1104
- Web
- https://www.medlive.cn/
- Phone
- Auditors
- Ernst & Young Australia
Upcoming Events for 2192
Half Year 2025 Medlive Technology Co Ltd Earnings Release
Similar to 2192
Activation group
Stock Exchange of Hong Kong Limited
Adtiger Corporations
Stock Exchange of Hong Kong Limited
AI X Tech
Stock Exchange of Hong Kong Limited
Alibaba Pictures
Stock Exchange of Hong Kong Limited
Allegro Culture
Stock Exchange of Hong Kong Limited
FAQ
What is the Medlive Technology Co share price?
As of Today at 21:58 UTC, shares in Medlive Technology Co are trading at HK$11.76. This share price information is delayed by 15 minutes.
How has the Medlive Technology Co share price performed this year?
Shares in Medlive Technology Co last closed at HK$11.76 and the price had moved by +37.7% over the past 365 days. In terms of relative price strength the Medlive Technology Co share price has outperformed the FTSE Developed Asia Pacific Index by +38.08% over the past year.
What are the analyst and broker recommendations for Medlive Technology Co?
The overall consensus recommendation for Medlive Technology Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Medlive Technology Co dividend yield?
The Medlive Technology Co dividend yield is 2.4% based on the trailing twelve month period.
Does Medlive Technology Co pay a dividend?
Last year, Medlive Technology Co paid a total dividend of CNY0.26, and it currently has a trailing dividend yield of 2.4%.Looking ahead, shares in Medlive Technology Co are due to go ex-dividend on 2025-05-12 and the next dividend pay date is 2025-06-06.
When does Medlive Technology Co next pay dividends?
Medlive Technology Co are due to go ex-dividend on 2025-05-12 and the next dividend pay date is 2025-06-06. The historic dividend yield on Medlive Technology Co shares is currently 2.4%.
How do I buy Medlive Technology Co shares?
To buy shares in Medlive Technology Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medlive Technology Co?
As of the previous close price of HK$11.76, shares in Medlive Technology Co had a market capitalisation of HK$8.53bn.
Where are Medlive Technology Co shares listed?
Here are the trading details for Medlive Technology Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2192
What kind of share is Medlive Technology Co?
Based on an overall assessment of its quality, value and momentum Medlive Technology Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medlive Technology Co share price forecast for 2025?
The analyst consensus target price for shares in Medlive Technology Co is HK$13.09. That is 11.35% above the last closing price of HK$11.76.
Analysts covering Medlive Technology Co currently have a consensus Earnings Per Share (EPS) forecast of CNY0.45 for the next financial year.
Find out moreWhat is the trend in the Medlive Technology Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medlive Technology Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +28.14%.
As of the last closing price of HK$11.76, shares in Medlive Technology Co were trading +18.69% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medlive Technology Co PE Ratio?
The Medlive Technology Co PE ratio based on its reported earnings over the past 12 months is 23.82. The shares last closed at HK$11.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medlive Technology Co?
Medlive Technology Co's management team is headed by:
- Liping Tian - CHM
- Lijun Tian - VPR
- Xin Zhou - VPR
- Jiangtao Xin - VPR
- Liancheng Yang - VPR
- Lixin Tian - EDR
- Juan Liu - OTH
- Jiang Nan - OTH
- Kar Yee Szeto - SEC
- Yanling Yang - SEC
- Zhuolin Li - NED
- Eiji Tsuchiya - NED
- Jun Ma - NID
- Shan Wang - NID
- Richard Yeh - NID